{"title":"Medication review in psychiatric patients with diabetes","authors":"Y. W. Francis Lam Pharm.D., FCCP","doi":"10.1002/pu.31333","DOIUrl":null,"url":null,"abstract":"<p>Research has suggested a possible link between antidepressants and increased risk of type 2 diabetes (Salvi et al., 2017). A higher prevalence of diabetes has also been reported in patients with schizophrenia (De Hert et al., 2009). Management of concurrent diabetes and psychiatric disorders could lead to polypharmacy, with risks of increased adverse drug effects and potential drug-drug interactions.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"36 8","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31333","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Research has suggested a possible link between antidepressants and increased risk of type 2 diabetes (Salvi et al., 2017). A higher prevalence of diabetes has also been reported in patients with schizophrenia (De Hert et al., 2009). Management of concurrent diabetes and psychiatric disorders could lead to polypharmacy, with risks of increased adverse drug effects and potential drug-drug interactions.